Literature DB >> 16275360

Role of regulatory T cells in human diseases.

Talal A Chatila1.   

Abstract

The discovery of regulatory T lymphocytes (Treg) that are actively involved in maintaining immune tolerance has led to new insights into mechanisms of tolerance breakdown in human diseases, including those resulting from allergic, autoimmune, or infectious causes. Congenital deficiency of CD4(+)CD25(+) Treg cells caused by loss-of-function mutations in the gene encoding Foxp3 triggers a syndrome of lymphoproliferation and myeloproliferation, autoimmunity, and allergic dysregulation, whereas deficient allergen-specific Treg cell responses have been associated with a number of allergic and autoimmune disorders. Tolerization to allergens and autoantigens is associated with augmentation of Treg cell numbers and suppressive function, suggesting the manipulation of Treg cell activity as a potential strategy for future therapeutic interventions in allergic and autoimmune diseases.

Entities:  

Mesh:

Year:  2005        PMID: 16275360     DOI: 10.1016/j.jaci.2005.08.047

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  67 in total

Review 1.  Immunosenescence of ageing.

Authors:  A L Gruver; L L Hudson; G D Sempowski
Journal:  J Pathol       Date:  2007-01       Impact factor: 7.996

2.  Conserved T cell receptor alpha-chain induces insulin autoantibodies.

Authors:  Masakazu Kobayashi; Jean Jasinski; Edwin Liu; Marcella Li; Dongmei Miao; Li Zhang; Liping Yu; Maki Nakayama; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-14       Impact factor: 11.205

Review 3.  T-regulatory cell-mediated immune tolerance as a potential immunotherapeutic strategy to facilitate graft survival.

Authors:  Mohammad A Khan; Sana Moeez; Suhail Akhtar
Journal:  Blood Transfus       Date:  2013-05-07       Impact factor: 3.443

4.  Molecular mechanisms of regulatory T cell development.

Authors:  Talal Chatila
Journal:  J Clin Immunol       Date:  2008-09-02       Impact factor: 8.317

Review 5.  Immunoparalysis and adverse outcomes from critical illness.

Authors:  W Joshua Frazier; Mark W Hall
Journal:  Pediatr Clin North Am       Date:  2008-06       Impact factor: 3.278

6.  Natural regulatory T cells control coronary arteriolar endothelial dysfunction in hypertensive mice.

Authors:  Khalid Matrougui; Zakaria Abd Elmageed; Abd Elmageed Zakaria; Modar Kassan; Sookyoung Choi; Devika Nair; Romer A Gonzalez-Villalobos; Aziz A Chentoufi; Philip Kadowitz; Souad Belmadani; Megan Partyka
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

7.  T regulatory cell mediated immunotherapy for solid organ transplantation: A clinical perspective.

Authors:  Mohammad Afzal Khan
Journal:  Mol Med       Date:  2016-11-22       Impact factor: 6.354

8.  Pulsed low-dose RANKL as a potential therapeutic for postmenopausal osteoporosis.

Authors:  Anna Cline-Smith; Jesse Gibbs; Elena Shashkova; Zachary S Buchwald; Deborah V Novack; Rajeev Aurora
Journal:  JCI Insight       Date:  2016-08-18

9.  CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling.

Authors:  Jennifer Kearley; Douglas S Robinson; Clare M Lloyd
Journal:  J Allergy Clin Immunol       Date:  2008-07-30       Impact factor: 10.793

10.  Lymphocyte subsets in pediatric migraine.

Authors:  Aron Cseh; Kristof Mark Farkas; Laszlo Derzbach; Katalin Muller; Barna Vasarhelyi; Balazs Szalay; Andras Treszl; Viktor Farkas
Journal:  Neurol Sci       Date:  2012-10-16       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.